Tylenol maker to pay $25 million for selling metal-contaminated drugs

A Johnson & Johnson subsidiary pleaded guilty on Tuesday to selling liquid medicine contaminated with metal and agreed to pay $25 million to resolve the case, the U.S. Department of Justice said on Tuesday. The subsidiary, McNeil Consumer Healthcare, pleaded guilty to one federal criminal charge in the case.

Read more: http://ift.tt/1BC9aq8